Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-06

Clinical Trial Update: Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating quercetin, bromelain, rye flower pollen and papain to reduce radiation-induced prostatitis in prostate cancer patients. The study was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromelain (bromelain)
  • Papain (Papain)
  • Quercetin (quercetin)
  • Rye flower pollen (Rye flower pollen)

Snippet

Sponsor: University of Utah | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-05-06